TABLE 2.
The results of method validation in terms of linearity, sensitivity, precision, and recovery.
| Name | Linear range (ng·mL−1) | Equation | R2 | LOD (ng·mL−1) | LOQ (ng·mL−1) | Precision a (mean ± SD) | Recovery a (RSD, %) |
|---|---|---|---|---|---|---|---|
| Cryptotanshinone | 0.01–100 | y = 1E-05x −1.5897 | 0.9919 | 0.009 | 0.030 | 48.23 ± 2.58 | 5.35 |
| Dihydrotanshinone | 0.01–100 | y = 2E-05x −2.1578 | 0.9916 | 0.003 | 0.010 | 53.72 ± 3.11 | 5.79 |
| Tanshinone IIA | 0.01–100 | y = 2E-05x −1.0208 | 0.9968 | 0.017 | 0.057 | 49.14 ± 2.12 | 4.31 |
| Tanshinone I | 0.01–100 | y = 5E-05x −1.2928 | 0.9962 | 0.010 | 0.033 | 49.80 ± 1.73 | 3.47 |
| Salvianate A sodium | 0.05–100 | y = 0.0003x −8.3986 | 0.9947 | 0.135 | 0.450 | 52.45 ± 2.08 | 3.97 |
| Salvianolic acid A | 0.05–100 | y = 9E-05x + 0.1683 | 0.9981 | 0.125 | 0.417 | 50.08 ± 1.02 | 2.04 |
| Rosmarinic acid | 0.05–100 | y = 0.0002x −8.1191 | 0.9954 | 0.090 | 0.300 | 47.58 ± 1.99 | 4.18 |
Spiked level 50 ngmL−1.